PharmaNordic ApS: Financial statements 2023
CVR: 36408464
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
PharmaNordic ApS (CVR 36408464) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 722,696 and a net result of DKK 515,361 compared with DKK 183,286 the year before. That is an increase of 25.8% compared with the year before. Equity in the 2023 report amounted to DKK 1,188,545. The solvency ratio was 77%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 722,696
- Profit/Loss
- DKK 515,361
- Equity
- DKK 1,188,545
- Total Assets
- DKK 1,543,045
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 723 t. | 515 t. | 1.2 mio. | 1 |
| 2022 | - | 575 t. | 183 t. | 673 t. | 1 |
| 2021 | - | 738 t. | 144 t. | 490 t. | - |
| 2020 | - | 517 t. | 574 t. | 346 t. | - |
| 2019 | - | 289 t. | -88 t. | -229 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
PharmaNordic ApS has published its annual report for 2022. Gross profit came to DKK 574,645, and the net result was DKK 183,286.
About PharmaNordic ApS
PharmaNordic ApS is a Danish company of the type Anpartsselskab based in Greve, founded in 2014. The company is registered under the industry Planlægning og design af reklamekampagner. The management consists of Anders Lentini From. The company is owned by LENTINI HOLDING ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK -197,662 and a net result of DKK 2,313,695 compared with DKK 647,775 the year before. Equity in the 2025 report amounted to DKK 4,025,013.